.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Moodys
Fuji
McKesson
Chubb
Cerilliant
Merck
Harvard Business School
QuintilesIMS
Express Scripts

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019353

« Back to Dashboard

NDA 019353 describes ALFENTA, which is a drug marketed by Akorn and Hospira and is included in two NDAs. It is available from one supplier. Additional details are available on the ALFENTA profile page.

The generic ingredient in ALFENTA is alfentanil hydrochloride. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the alfentanil hydrochloride profile page.

Summary for 019353

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details

Pharmacology for NDA: 019353

Mechanism of ActionFull Opioid Agonists

Medical Subject Heading (MeSH) Categories for 019353

Suppliers and Packaging for NDA: 019353

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALFENTA alfentanil hydrochloride INJECTABLE;INJECTION 019353 NDA Akorn, Inc. 17478-067 17478-067-02 10 AMPULE in 1 CARTON (17478-067-02) > 2 mL in 1 AMPULE
ALFENTA alfentanil hydrochloride INJECTABLE;INJECTION 019353 NDA Akorn, Inc. 17478-067 17478-067-20 5 AMPULE in 1 CARTON (17478-067-20) > 20 mL in 1 AMPULE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 0.5MG BASE/ML
Approval Date:Dec 29, 1986TE:APRLD:Yes

Expired Orange Book Patents for NDA: 019353

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
AkornALFENTAalfentanil hydrochlorideINJECTABLE;INJECTION019353-001Dec 29, 1986► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Healthtrust
Accenture
Deloitte
Farmers Insurance
AstraZeneca
Baxter
Cantor Fitzgerald
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot